Skip to main content

Evaluate the outcome of pneumonectomy for stage III a-N2 NSCLC

Background/Introduction

The effect of surgery in patients with III a-N2 non-small cell lung cancer is not certain.

Aims/Objectives

We intend to evaluate the outcome of pneumonectomy in III a-N2 non-small cell lung cancer.

Method

We retrospectively reviewed the cases of patients with III a-N2 non-small cell lung cancer, who underwent pneumonectomy from April 2003 to January 2014 at a single institution.

Results

During the study, 184 patients underwent surgical resection of stage III a-N2 non-small cell lung cancer. Among them, 35 patients had pneumonectomy, 29 patients (83%) were male, and 6 (17%) were female. The median age was 57 years (43 yrs-77 yrs) old, and the median follow up duration was 77 month. 27 patients (77%) had induction chemotherapy before operation. Right pneumonectomy was performed in 13 patients (37%), and Left pneumonectomy was done in 22 patients (63%). The 5-year survival was 58% in pneumonectomy, 28% in the right pneumonectomy and 76% in the left pneumonectomy, respectively. Left pneumonectomy(p = 0.021) and complete resectability (p = 0.017) were positive prognostic factor, but the induction chemotherapy before operation was negative prognostic factor. (p = 0.040)

Discussion/Conclusion

The side of operation and complete resectability are positive prognostic factor, but the induction chemotherapy is negative prognostic factor for pneumonectomy in III a-N2 NSCLC patients.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Kwhanmien Kim.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Park, S., Jang, HJ., Yi, E. et al. Evaluate the outcome of pneumonectomy for stage III a-N2 NSCLC. J Cardiothorac Surg 10, A206 (2015). https://doi.org/10.1186/1749-8090-10-S1-A206

Download citation

Keywords

  • Public Health
  • Lung Cancer
  • Prognostic Factor
  • Cardiac Surgery
  • Surgical Resection